We note, however, that while 55% of thyroid nodules within this study were benign at the time of surgery, their natural history, including the possible progression to a malignancy and/or the acquisition of a second mutation (eg., TP53 or TERT) if they were not removed, is unknown. The gene discussed is TP53; the disease is thyroid nodule.